| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.0006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |